Organised by The Lancet Oncology, in collaboration with four Lancet journals, a renowned Advisory Board will bring together a stellar faculty of approximately 40 speakers to tackle the challenges posed by the major cancers in China through a lens of cancer control.

A contemporary programme will include:

- cross-cutting plenary sessions
- three parallel tracks covering lung, gastrointestinal, and breast cancer
- a unique half-day symposium - organised in association with CReDO - dedicated to the importance, design, and critical appraisal of clinical trials
- oral abstract presentations
- poster sessions
- exhibition area


Call for abstracts

Abstracts are invited by Sept 23, 2024. A selection of the best abstracts will be nominated for oral presentation, the rest will be poster only. All accepted abstracts will be published in The Lancet Regional Health—Western Pacific.